Ovariopexy for Adhesion Prevention After Laparoscopic Removal of Endometriosis of the Pelvic Side Wall or the Ovary
Not Applicable
Completed
- Conditions
- AdhesionEndometriosisSurgery
- Interventions
- Procedure: placebo operationProcedure: ovariopexy
- Registration Number
- NCT04669756
- Lead Sponsor
- University Hospital Muenster
- Brief Summary
prospective randomized Trial comparing ovariopexy over 2, 4 or 6 days vs Placebo after surgery because of endometriosis of the pelvic side wall or the ovary or both
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 409
Inclusion Criteria
- premenopausal
- wants to participate
- removal of endometriosis of the pelvic side wall or ovary
Exclusion Criteria
- postmenopausal
- cannot give informed consent
- no endometriosis during Operation
- no Opening of pelvic side wall or ovary during the Operation
- pregnant
- breast feeding
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description D placebo operation Placebo Operation for 2 days A ovariopexy ovariopexy for 2 days B ovariopexy ovariopexy for 4 days C ovariopexy ovariopexy for 6 days
- Primary Outcome Measures
Name Time Method prevalence of postoperative ovarian adhesions 3 months after operation prevalence of postoperative ovarian adhesions
- Secondary Outcome Measures
Name Time Method postoperative infectious complications up to 3 months after operation postoperative infectious complications
postoperative pain daily during postoperative hospitalisation and at follow up visit after 3 months postoperative pain (NRS)
AMH at follow up visit after 3 months AMH level
Trial Locations
- Locations (1)
University Hospital Muenster
🇩🇪Münster, NRW, Germany